Johnson & Johnson (NYSE: JNJ) offered $438 million in cash to buy Omrix Biopharmaceuticals Inc. (Nasdaq: OMRI) to add to its surgical products business. Shares of Johnson & Johnson eased 8 cents to $58.27 while Omrix stock leaped $3.57 to $24.73.
Johnson & Johnson To Buy Omrix
November 24, 2008 at 13:56 PM EST
